Journal of Cachexia Sarcopenia and Muscle

Papers
(The H4-Index of Journal of Cachexia Sarcopenia and Muscle is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis548
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021335
Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults232
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review209
Understanding the gut microbiota and sarcopenia: a systematic review161
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19138
Effects of statins on mitochondrial pathways124
The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.112
Mouse models of sarcopenia: classification and evaluation109
Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis103
Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study97
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers95
Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality92
Systematic review and meta‐analysis of protein intake to support muscle mass and function in healthy adults88
Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS87
Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis86
Gut microbes and muscle function: can probiotics make our muscles stronger?83
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting82
Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy81
Exercise for sarcopenia in older people: A systematic review and network meta‐analysis79
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients77
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China74
Roles of nutrition in muscle health of community‐dwelling older adults: evidence‐based expert consensus from Asian Working Group for Sarcopenia73
Computed tomography‐defined low skeletal muscle index and density in cancer patients: observations from a systematic review70
Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis70
Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal women69
Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study69
Single‐cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle67
Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial65
Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study64
Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis64
How gait influences frailty models and health‐related outcomes in clinical‐based and population‐based studies: a systematic review61
ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke58
Normative values of muscle strength across ages in a ‘real world’ population: results from the longevity check‐up 7+ project58
Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia57
Probiotic supplementation attenuates age‐related sarcopenia via the gut–muscle axis in SAMP8 mice57
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross‐sectional survey (NutriAgeCancer)56
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis55
Age‐related alterations in muscle architecture are a signature of sarcopenia: the ultrasound sarcopenia index53
Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐753
The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review52
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies52
Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a51
Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis51
Muscle strength and incidence of depression and anxiety: findings from the UK Biobank prospective cohort study50
The beneficial therapeutic effects of plant‐derived natural products for the treatment of sarcopenia49
Meta‐analysis of genome‐wide DNA methylation and integrative omics of age in human skeletal muscle49
Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual‐energy X‐ray absorptiometry48
Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer48
0.042841911315918